Free Trial
NASDAQ:SOPH

SOPHiA GENETICS (SOPH) Stock Price, News & Analysis

SOPHiA GENETICS logo
$3.96 +0.03 (+0.76%)
Closing price 09/23/2025 04:00 PM Eastern
Extended Trading
$3.98 +0.02 (+0.63%)
As of 09/23/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SOPHiA GENETICS Stock (NASDAQ:SOPH)

Advanced

Key Stats

Today's Range
$3.82
$4.02
50-Day Range
$3.01
$3.96
52-Week Range
$2.58
$4.92
Volume
118,226 shs
Average Volume
42,506 shs
Market Capitalization
$267.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Buy

Company Overview

SOPHiA GENETICS Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

SOPH MarketRank™: 

SOPHiA GENETICS scored higher than 30% of companies evaluated by MarketBeat, and ranked 785th out of 946 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SOPHiA GENETICS has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    SOPHiA GENETICS has a consensus price target of $8.00, representing about 102.0% upside from its current price of $3.96.

  • Amount of Analyst Coverage

    SOPHiA GENETICS has received no research coverage in the past 90 days.

  • Read more about SOPHiA GENETICS's stock forecast and price target.
  • Earnings Growth

    Earnings for SOPHiA GENETICS are expected to grow in the coming year, from ($0.96) to ($0.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SOPHiA GENETICS is -9.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SOPHiA GENETICS is -9.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SOPHiA GENETICS has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about SOPHiA GENETICS's valuation and earnings.
  • Percentage of Shares Shorted

    0.08% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently increased by 6.11%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    SOPHiA GENETICS does not currently pay a dividend.

  • Dividend Growth

    SOPHiA GENETICS does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.08% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently increased by 6.11%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for SOPHiA GENETICS this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for SOPH on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SOPHiA GENETICS insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.88% of the stock of SOPHiA GENETICS is held by insiders.

  • Percentage Held by Institutions

    Only 31.59% of the stock of SOPHiA GENETICS is held by institutions.

  • Read more about SOPHiA GENETICS's insider trading history.
Receive SOPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SOPH Stock News Headlines

3 Penny Stocks With Market Caps Over $100M And Promising Growth
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
Sophia Genetics management to meet with Craig-Hallum
See More Headlines

SOPH Stock Analysis - Frequently Asked Questions

SOPHiA GENETICS's stock was trading at $3.07 at the beginning of 2025. Since then, SOPH shares have increased by 29.0% and is now trading at $3.96.

SOPHiA GENETICS SA (NASDAQ:SOPH) issued its earnings results on Tuesday, August, 5th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of ($0.25) by $0.58. The business earned $18.32 million during the quarter, compared to the consensus estimate of $17.49 million. SOPHiA GENETICS had a negative net margin of 40.99% and a negative trailing twelve-month return on equity of 30.69%.
Read the conference call transcript
.

SOPHiA GENETICS (SOPH) raised $234 million in an initial public offering on Friday, July 23rd 2021. The company issued 13,000,000 shares at $17.00-$19.00 per share.

SOPHiA GENETICS's top institutional shareholders include Akre Capital Management LLC (5.50%), Archon Capital Management LLC (0.48%), Ensign Peak Advisors Inc (0.37%) and Federated Hermes Inc. (0.33%).

Shares of SOPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SOPHiA GENETICS investors own include Occidental Petroleum (OXY), PayPal (PYPL), Chesapeake Energy (CHK), Cheniere Energy (LNG), Rocket Pharmaceuticals (RCKT), AbCellera Biologics (ABCL) and Farmers & Merchants Bancorp (FMAO).

Company Calendar

Last Earnings
8/05/2025
Today
9/23/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SOPH
CIK
1840706
Fax
N/A
Employees
520
Year Founded
2011

Price Target and Rating

High Price Target
$11.00
Low Price Target
$5.00
Potential Upside/Downside
+102.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.44)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.49 million
Net Margins
-40.99%
Pretax Margin
-102.43%
Return on Equity
-30.69%
Return on Assets
-17.39%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
3.39
Quick Ratio
3.21

Sales & Book Value

Annual Sales
$65.17 million
Price / Sales
4.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.48 per share
Price / Book
2.68

Miscellaneous

Outstanding Shares
67,580,000
Free Float
64,282,000
Market Cap
$267.62 million
Optionable
Not Optionable
Beta
1.01

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:SOPH) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners